VSee Health has launched a specialized program to tackle obesity and related health risks by integrating GLP-1 prescription medicines into its telehealth services. The program builds on VSee Health’s existing virtual urgent care, primary care, and wellness offerings, combining telehealth access, prescription support, and behavioral intervention to deliver impactful care through virtual channels.
"We are excited to expand the company’s capabilities with the launch of this GLP-1 initiative," said Imo Aisiku, MD, co-CEO and Chairman of VSee Health. "By facilitating access to GLP-1 drugs through our telehealth platform, we can better serve populations with the highest need and empower individuals in underrepresented communities to take control of their health, reduce cardiovascular risks, and prevent long-term complications."
Participants benefit from personalized care plans, access to GLP-1 medications, and virtual support sessions to promote adherence and sustained weight loss. The program’s effectiveness will be measured through both participant and community-level outcomes.
With subscriptions available at $4.99 per month and virtual appointments, VSee Health continues to provide affordable, quality healthcare solutions that address disparities and improve patient outcomes.
See the official announcement here.
